Core Cap Advisors, LLC Pfizer Inc Transaction History

Core Cap Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 08, 2024	BUY	$25.89 - $29.73 $1.69 Million - $1.94 Million	65,143 New	65,143 $1.81 Million
Q4 2023 Jan 12, 2024	SELL	$26.13 - $33.94 $44,525 - $57,833	-1,704 Reduced 3.36%	49,008 $1.41 Million
Q3 2023 Jan 12, 2024	BUY	$32.09 - $37.51 $76,887 - $89,873	2,396 Added 4.96%	50,712 $1.68 Million
Q2 2023 Jan 12, 2024	SELL	$36.12 - $41.79 $626,284 - $724,596	-17,339 Reduced 26.41%	48,316 $1.77 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $965,928 - $1.26 Million	23,136 Added 54.41%	65,655 $3.37 Million
Q3 2022 Feb 10, 2023	SELL	$43.76 - $53.42 $612,071 - $747,185	-13,987 Reduced 24.75%	42,519 $1.86 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $687,387 - $815,026	14,773 Added 35.4%	56,506 $2.96 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $621,971 - $770,700	-13,595 Reduced 24.57%	41,733 $2.16 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $2.29 Million - $3.39 Million	55,328 New	55,328 $3.27 Million

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Core Cap Advisors, LLC with notifications on news.